News on ophthalmology and intraocular lenses
Eyedeal xPIB IOL
Former FDA CDRH Director of Device Evaluation and Pantheon Vision President/CEO, Dr. John Sheets, recently visited…
On October 12 to 15, the 2023 Chinese Biomaterials Congress (CSBM2023) was held in Chongqing, China. Dr. Leonard…
The American Academy of Ophthalmology (AAO) recently presented Professor Gerd U. Auffarth, scientific advisor of Xi’an…
Editor's note: Robert Ward, member of the Scientific Advisory Committee of Xi′an Eyedeal Medical Technology Co., Ltd.…
Xi’an Eyedeal Medical Technology announced that it completed the enrollment of its xPIB intraocular lens clinical trial…
Lately, the world-renowned "Edison Award" announced the winners of 2022. Robert Ward, Scientific Advisor of Xi’an…
Eyedeal Medical successfully held a press conference about the cross-linked polyolefin intraocular lens clinical trial…
International Conference on Medical Device Supervision and Administration From September 24 to 26, the 12th…
On November 4, Xi'an Science and Technology Bureau identified Xi'an Ophthalmology Biomaterials Engineering Technology…
On May 21, the official NMPA website announced that cross-linked polyisobutylene intraocular lenses declared by Xi'an…
The Human Resources and Social Security Department of Shaanxi Province has confirmed approval for Xi'an Eyedeal Medical…
On May 24 Xi'an Eyedeal Medical Technology Co., Ltd. hosted an event to launch its academician expert workstation.…
On January 24, the Organization Department of the Xi’an Municipal Committee of the Communist Party of China and the…
On November 5, Zhong Hongjiang, member of the Standing Committee of the Xi'an Municipal Party Committee, Secretary of…
The 2017 annual meeting of the "National Key R&D Program" led by Xi'an Eyedeal Medical Technology Co., Ltd. was held…
This interview was conducted October 13 at the National Key R&D Program key special project kick-off meeting and…
On October 13, Xi'an Eyedeal’s National Key R&D Program event was hosted by the China Biotechnology Development…